Research analysts at William Blair upped their FY2025 EPS estimates for shares of ABM Industries in a report issued on ...

Stock analysts at William Blair lowered their FY2026 earnings estimates for Ferguson in a research report issued on Tuesday, ...

We recently compiled a list of the 10 AI Stocks Investors Are Watching Closely Right Now. In this article, we are going to ...

William Blair downgraded Udemy (UDMY) to Market Perform from Outperform after the company announced the appointment of Hugo Sarrazin as ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Udemy (NasdaqGS:UDMY) from Outperform to ...

Fintel reports that on March 11, 2025, William Blair upgraded their outlook for Genmab A (NasdaqGS:GMAB) from Market Perform ...

JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on ...

William Blair analyst Andy Hsieh reiterated a Hold rating on Nektar Therapeutics (NKTR – Research Report) today. The company’s shares closed ...

The firm upgraded Palantir from Underperform to Market Perform after a sharp stock decline but did not assign a price target.

The embedded finance company, which posted a loss last year, hired Citi to explore its strategic options and named an interim ...

Autism software provider CentralReach has been looking for a potential buyer, according to multiple sources with knowledge of ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...